Hematology analyzers are critical for medical settings as they are used to count and characterize blood cells for disease detection and monitoring. The recent Top 50 Hematology In-Vitro Diagnostics Analyzers, Reagents & Accessories report published by Reportlinker identifies and profiles the 50 leading developers of hematology in-vitro diagnostics analyzers, and reagents. These companies have the experience, know how and resources that enable them to develop, manufacture and market innovative products that compete effectively in worldwide markets. This new report looks at all 50 of the top companies including EKF Diagnostics Holdings, Diagnostics Holdings, Drucker Diagnostics, Diatron Medical Instruments, and ELITechGroup Molecular Diagnostics among others.
The target market for this report includes in-vitro diagnostics companies, suppliers, distributors, and industry associations. In-vitro diagnostics companies can use this report for competitive/financial analysis and strategic partner/alliance identification, while this is perfect for suppliers of raw materials, technology and services to identify top potential customers. Meanwhile, distributors can use this to identify the leading manufacturers with the best products and it also serves as a useful reference tool for in-vitro diagnostic associations.
Other reports are also available that highlight the current and upcoming growth, trends and forecast for the Global Hematology Analyzer market. According to a report from Markets and Markets, the global hematology instruments and reagents market is expected to reach $3.13 billion by 2019. A number of factors drive the growth of this market and include development of the high throughput hematology analyzers, integration of basic flow-cytometry techniques in modern hematology analyzers, increasing adoption of automated hematology instruments by diagnostics laboratories, technological advancements, and developments in high sensitivity point-of-care (POC) hematology testing. However, slow adoption of advanced hematology instruments in the emerging economies, hematology product recalls, and high cost of hematology analyzers are factors restricting the growth of the global market.
Key players mentioned in the market report include Sysmex Corporation (Japan), Beckman Coulter, Inc. (U.S.), Abbott Laboratories (U.S.), HORIBA, Ltd. (Japan), Siemens AG (Germany), Bio-Rad Laboratories, Inc. (U.S.), and others.